TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,093,000 | -40.8% | 271,067 | -26.3% | 0.07% | -34.0% |
Q2 2021 | $3,535,000 | -31.9% | 367,817 | -3.9% | 0.10% | -34.2% |
Q1 2021 | $5,191,000 | -79.4% | 382,553 | -78.3% | 0.15% | -80.6% |
Q4 2020 | $25,253,000 | -32.7% | 1,763,476 | -13.3% | 0.78% | -31.9% |
Q3 2020 | $37,549,000 | +661.0% | 2,032,988 | +137.4% | 1.15% | +670.5% |
Q2 2020 | $4,934,000 | +121.9% | 856,517 | +47.9% | 0.15% | +79.5% |
Q1 2020 | $2,224,000 | -20.8% | 579,217 | +10.3% | 0.08% | -4.6% |
Q4 2019 | $2,809,000 | – | 525,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |